Evidence map›Paper›PMID 28992407›Full record

ArticleJournal of the American Chemical Society2017

Perfluoroarene-Based Peptide Macrocycles to Enhance Penetration Across the Blood-Brain Barrier.

Colin M Fadzen, Justin M Wolfe, Choi-Fong Cho, E Antonio Chiocca, Sean E Lawler, Bradley L Pentelute

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Ultra-rapid Electrophilic Cysteine Arylation.Journal of the American Chemical Society · 2023
    Article
  13. Article
  14. First Potent Macrocyclic AACS pharmacology & translational science · 2023
    Article
  15. Review
  16. Article
  17. A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Colin M FadzenDepartment of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
Justin M WolfeDepartment of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
Choi-Fong ChoHarvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
E Antonio ChioccaHarvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
Sean E LawlerHarvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts 02115, United States.
Bradley L PenteluteDepartment of Chemistry, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.ORCID 0000-0002-7242-801X

Funding

Cysteine ArylationR01GM110535 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI PENTELUTE, BRADLEY LETHER · 2014 to 2018
$1.5M
NIGMS NIH HHS R01 GM110535
6 · The paper itself

Abstract

Here we describe the utility of peptide macrocyclization through perfluoroaryl-cysteine S

Indexed as

AnimalsBcl-2-Like Protein 11Blood-Brain BarrierCell LineCell-Penetrating PeptidesMacrocyclic CompoundsMiceParenchymal TissuePeptidesProtein StabilityProtein TransportRecombinant Fusion ProteinsSpheroids, CellularBcl-2-Like Protein 11Cell-Penetrating PeptidesMacrocyclic CompoundsPeptidesRecombinant Fusion Proteinstransportan-10

Identifiers

PMID28992407
PMCPMC5818988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.